Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Exxon Mobil | 11.46% | $813.21M | $630.06B | 38.70% | 74 Outperform | |
| Chevron | 9.38% | $665.49M | $379.00B | 21.49% | 71 Outperform | |
| Verizon | 8.29% | $588.19M | $215.61B | 10.98% | 81 Outperform | |
| Pfizer | 5.89% | $417.80M | $153.81B | 1.20% | 74 Outperform | |
| Merck & Company | 5.42% | $384.35M | $286.28B | 22.33% | 80 Outperform | |
| PepsiCo | 4.91% | $348.25M | $217.88B | 3.23% | 78 Outperform | |
| Altria Group | 4.69% | $332.90M | $111.20B | 15.09% | 64 Neutral | |
| Bristol-Myers Squibb | 3.39% | $240.44M | $122.78B | -1.31% | 78 Outperform | |
| Comcast | 3.30% | $234.17M | $114.81B | -15.11% | 74 Outperform | |
| Conocophillips | 3.00% | $213.13M | $143.10B | 29.17% | 78 Outperform |